Brief: Immunoprecise Antibodies Ltd Entered Into Sales Agreement Relating To Sale Of Common Shares Offered By The Prospectus Supplement
Feb 23 (Reuters) - Immunoprecise Antibodies Ltd IPA.O :
* IMMUNOPRECISE ANTIBODIES LTD - HAVE ENTERED INTO SALES
AGREEMENT
RELATING TO SALE OF COMMON SHARES OFFERED BY THE PROSPECTUS
SUPPLEMENT
* IMMUNOPRECISE ANTIBODIES - MAY OFFER AND SELL COMMON
SHARES OF
UP TO U.S.$60 MILLION FROM TIME TO TIME
Source text for Eikon: ID:n0001062993-24-004316
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai